Description:
The aim of this new area is to standardize the processes for tissue-engineered regenerative medicine therapies to bring down costs and to make the manufacturing processes more reproducible, economical, efficient, and sustainable. This may include the development of manufacturing technology for tissue engineering, including the construction of whole human tissues and organs for drug screening and transplants, as well as cell-based and personalized therapies, or regenerative medicine, that use cells as part of patches and implants.